Suzanne Bakker, Netherlands Cancer Institute (NKI)
The Netherlands Cancer Institute (NKI) was established on October 10, 1913. Initially comprising one clinic room for patients and a smaller laboratory that could accommodate up to 10 scientists, it has grown considerably and is now home to more than 600 scientists, scientific support personnel and medical specialists; 5 operating theatres; 9 irradiation units and 180 beds.
From the start, the institute’s mission was to create a facility where “patients suffering from malignant growths” could be treated adequately and where the study of cancer and related diseases could be carried out. Today, the institute’s reputation for being a leading center of excellence for cancer-related research, development and training is global. A key contributory factor to this success is the institute’s collaborative approach of combining a hospital and laboratory as one organisation. Clinicians, researchers and students work together in teams to rapidly translate new knowledge into prototype therapies which are then trialled in the clinic. This has led to the institute’s many discoveries to improve cancer therapies and develop better diagnosis.
Since 2008, NKI has been a Springer customer. Initially purchasing Springer ebook and ejournal titles on an individual basis, the Institute decided to upgrade their holdings to include collections of titles that were relevant for their subject specialties. As Suzanne Bakker, Librarian Central Cancer Library and President & Supervisor EAHIL Secretariat, commented at the time of purchase, “Springer eBooks are indexed in several online databases, such as Google & PubMed - one of our most used online interfaces - therefore they are easily found by our end-users. Also the ownership model that Springer offers for ebooks was very interesting for us.”
NKI now has access to Springer’s biomedical life sciences and medicine ebook and ejournal packages as well as the Springer Protocols database. “We were positively surprised by Springer Protocols. The usage during the trial period was really high. The integrated access on SpringerLink, the availability on PubMed, coupled with the quality of the product, was also very much appreciated and needed for our daily research on cancer.”
To remain current in their field of expertise, it is essential for NKI’s researchers to have access to good quality, up-to-date scholarship. Not only does this help progress their own research, but it assists in developing networks and collaborations that may speed other new discoveries. Suzanne Bakker further commented: “Springer provides good quality content. Accessing the content is straightforward and easy, plus the depth and breadth of subject coverage, as well as the affordable business model, means that Springer was a good fit for our library collection profile. This has certainly been confirmed by our usage – we expected good use of our medical titles but have been delighted to find that our users find the non-medical titles just as relevant; plus usage of Springer Protocols continues to remain high. ”